PACTR202009822379650招募中4 期
Two-way risk communication mobile application use versus traditional methods of adverse drug reaction reporting in Uganda: a cluster-randomized controlled trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 3,820
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •All health facilities where antiretroviral therapy is prescribed and dispensed to people living with HIV and at least one healthcare professional owns a smartphone.
排除标准
- •Health facilities where none of the healthcare professionals owns a smartphone.
研究者
相似试验
招募中
不适用
Examining the Effectiveness of Mobile Telephone Communication Interventions on the Utilization of Antenatal Care Services Among Expectant Mothers in the Districts of Rakai and Kyotera in Uganda: Study Protocol for a Randomized Controlled Trial.Antenatal Care Utilization with exposure to mobile telephone communication reminders.PACTR202205826916525The Regional Universities Forum for Capacity Building in Agriculture2,214
进行中（未招募）
2 期
GuARD - GR1014 cutaneous gel Against Radiation DermatitisRadiodermatitis occurring with adjuvant radiotherapy for localised breast cancer after lumpectomySkin and Connective Tissue DiseasesISRCTN61697120Graegis Pharmaceuticals Ltd273
进行中（未招募）
不适用
A randomized, double-blind, vehicle-controlled, multicenter, parallel group study to assess the efficacy, safety, and tolerability of topical terbinafine hydrogen chloride (HCl) formulation for 24 or 48 weeks of treatment in patients with mild to moderate toenail onychomycosisOnychomycosis (mild to moderate)MedDRA version: 8.1Level: LLTClassification code 10030338Term: OnychomycosisEUCTR2006-003508-21-DEovartis Pharma Services AG500
进行中（未招募）
1 期
A randomized, double-blind, vehicle-controlled, multicenter, parallel group study to assess the efficacy, safety, and tolerability of topical terbinafine hydrogen chloride (HCl) formulation for 24 or 48 weeks of treatment in patients with mild to moderate toenail onychomycosisOnychomycosis (mild to moderate)MedDRA version: 8.1Level: LLTClassification code 10030338Term: OnychomycosisEUCTR2006-003506-25-ISovartis Pharma Services AG500
进行中（未招募）
不适用
A randomized, double-blind, vehicle-controlled, multicenter trial of topically administered LDE225 cream [0.75% bid] to evaluate clearance of Basal Cell Carcinoma in adult patients with Nevoid Basal Cell Carcinoma Syndrome - NDBasal Cell Carcinoma in adult patients with Nevoid Basal Cell Carcinoma SyndromeMedDRA version: 12.1Level: LLTClassification code 10004146Term: Basal cell carcinomaEUCTR2010-019856-30-ITOVARTIS FARMA109